Illumina Net Worth
Illumina Net Worth Breakdown | ILMN |
Illumina Net Worth Analysis
Illumina's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Illumina's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Illumina's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Illumina's net worth analysis. One common approach is to calculate Illumina's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Illumina's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Illumina's net worth. This approach calculates the present value of Illumina's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Illumina's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Illumina's net worth. This involves comparing Illumina's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Illumina's net worth relative to its peers.
Enterprise Value |
|
To determine if Illumina is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Illumina's net worth research are outlined below:
| Illumina currently holds 2.26 B in liabilities with Debt to Equity (D/E) ratio of 0.38, which is about average as compared to similar companies. Illumina has a current ratio of 0.91, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Illumina's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 4.5 B. Net Loss for the year was (1.16 B) with profit before overhead, payroll, taxes, and interest of 3.15 B. | |
| Over 95.0% of Illumina shares are owned by institutional investors | |
| Latest headline from gurufocus.com: Myriad Genetics Announces Incorporation of its Proprietary HRD p |
Illumina Quarterly Good Will |
|
Illumina uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Illumina. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Illumina's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 8th of February 2024 Upcoming Quarterly Report | View | |
| 23rd of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 8th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Illumina's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Illumina is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Illumina backward and forwards among themselves. Illumina's institutional investor refers to the entity that pools money to purchase Illumina's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Primecap Management Company | 2024-09-30 | 2.5 M | Alliancebernstein L.p. | 2024-06-30 | 2.5 M | Corvex Management Lp | 2024-06-30 | 2.3 M | Norges Bank | 2024-06-30 | 2.1 M | Nuveen Asset Management, Llc | 2024-06-30 | 1.9 M | Bank Of America Corp | 2024-06-30 | 1.6 M | Legal & General Group Plc | 2024-06-30 | 1.6 M | Hhg Plc | 2024-06-30 | 1.5 M | Millennium Management Llc | 2024-06-30 | 1.5 M | Blackrock Inc | 2024-06-30 | 18.1 M | Vanguard Group Inc | 2024-09-30 | 15.9 M |
Follow Illumina's market capitalization trends
The company currently falls under 'Large-Cap' category with a current market capitalization of 20.88 B.Market Cap |
|
Project Illumina's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.25) | (0.24) | |
| Return On Capital Employed | (0.13) | (0.12) | |
| Return On Assets | (0.11) | (0.11) | |
| Return On Equity | (0.20) | (0.19) |
When accessing Illumina's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Illumina's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Illumina's profitability and make more informed investment decisions.
Evaluate Illumina's management efficiency
Illumina has return on total asset (ROA) of 0.0262 % which means that it generated a profit of $0.0262 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3951) %, meaning that it created substantial loss on money invested by shareholders. Illumina's management efficiency ratios could be used to measure how well Illumina manages its routine affairs as well as how well it operates its assets and liabilities. As of the 21st of November 2024, Return On Tangible Assets is likely to grow to -0.24. In addition to that, Return On Capital Employed is likely to grow to -0.12. At this time, Illumina's Debt To Assets are very stable compared to the past year. As of the 21st of November 2024, Fixed Asset Turnover is likely to grow to 3.35, while Non Currrent Assets Other are likely to drop about 123.4 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 36.36 | 38.18 | |
| Tangible Book Value Per Share | 1.31 | 1.24 | |
| Enterprise Value Over EBITDA | (37.16) | (35.30) | |
| Price Book Value Ratio | 3.72 | 5.32 | |
| Enterprise Value Multiple | (37.16) | (35.30) | |
| Price Fair Value | 3.72 | 5.32 | |
| Enterprise Value | 1.5 B | 1.6 B |
Illumina has shown resilience through effective management strategies. Our analysis examines how these strategies influence financial outcomes and investor returns which helps in understanding the stock's long-term potential.
Enterprise Value Revenue 5.2724 | Revenue 4.4 B | Quarterly Revenue Growth (0.04) | Revenue Per Share 27.654 | Return On Equity (0.40) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Illumina insiders, such as employees or executives, is commonly permitted as long as it does not rely on Illumina's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Illumina insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Jacob Thaysen over a month ago Disposition of 914 shares by Jacob Thaysen of Illumina at 140.66 subject to Rule 16b-3 | ||
Jacob Thaysen over a month ago Acquisition by Jacob Thaysen of 7426 shares of Illumina subject to Rule 16b-3 | ||
Ullem Scott B. over six months ago Acquisition by Ullem Scott B. of 163 shares of Illumina at 137.682 subject to Rule 16b-3 | ||
Roy Whitfield over a year ago Exercise or conversion by Roy Whitfield of 800 shares of Illumina subject to Rule 16b-3 |
Illumina Corporate Filings
13A | 12th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
F4 | 7th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10Q | 6th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
F3 | 15th of October 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
Illumina Earnings per Share Projection vs Actual
Illumina Corporate Management
| Steven Hoffman | Segment Sequencing | Profile | |
| Pat Leckman | Interim Officer | Profile | |
| Ankur Dhingra | Chief Officer | Profile | |
| Nicole Berry | Head RegionAmericas | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Illumina. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. To learn how to invest in Illumina Stock, please use our How to Invest in Illumina guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Illumina. If investors know Illumina will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Illumina listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.96) | Earnings Share (9.98) | Revenue Per Share 27.654 | Quarterly Revenue Growth (0.04) | Return On Assets 0.0262 |
The market value of Illumina is measured differently than its book value, which is the value of Illumina that is recorded on the company's balance sheet. Investors also form their own opinion of Illumina's value that differs from its market value or its book value, called intrinsic value, which is Illumina's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Illumina's market value can be influenced by many factors that don't directly affect Illumina's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Illumina's value and its price as these two are different measures arrived at by different means. Investors typically determine if Illumina is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Illumina's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.